Spero Therapeutics, Inc.SPRONASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Over Time
Trending lower, below historical average, strong compound growth.
Left:
||||
Revenue minus cost of goods sold
Latest
$-48.78M
↓ 256% below average
Average (9y)
$-13.69M
Historical baseline
Range
High:$52.34M
Low:$-57.67M
CAGR
+154.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-48.78M | -193.2% |
| 2023 | $52.34M | +7.7% |
| 2022 | $48.58M | +1482.4% |
| 2021 | $3.07M | +105.3% |
| 2020 | $-57.67M | -21.1% |
| 2019 | $-47.63M | -59.2% |
| 2018 | $-29.92M | +3.1% |
| 2017 | $-30.89M | -18.8% |
| 2016 | $-26.00M | -236245.5% |
| 2015 | $-11000.00 | - |